RICHMOND, Calif. (January 11, 2016)—Ekso Bionics Holdings, Inc. a leading global robotic exoskeleton company, announced a new randomized comparative clinical trial is currently underway in Europe. The trial is called, “The MOST Study,” (Mobility improved after stroke when a robotic device was used in comparison to physical therapy) and is being initialized by Professor Dr. med. F. Hamzei, MD, MHBA, Chief physician of Department of Neurological Rehabilitation, Moritz Klinik.